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Aims. We evaluated the interaction eﬀect between depressive symptoms and dietary habits on 30-day development of
cardiovascular disease (CVD) (death or rehospitalization) in elderly, acute coronary syndrome (ACS) survivors. Methods.
During 2006–2008, we recorded 277 nonfatal, consecutive ACS admissions (75 ± 6years, 70% males, 70% had diagnosis of
myocardial infarction) with complete 30-day follow-up. Assessment of recent depressive symptoms was based on the CES-D
scale. Among sociodemographic, bioclinical, lifestyle characteristics, the MedDietScore that assesses the inherent characteristics
of the Mediterranean diet was applied. Results. 22% of the ACS pts developed a CVD event during the ﬁrst 30 days (14.8%
rehospitalization and 9.4% death). Patients in the upper tertile of the CES-D scale (i.e., >18) had higher incidence of CVD events
as compared with those in the lowest tertile (21% versus 8%, P = .01). Multiple logistic regression analysis revealed that 1-
unit increase in CES-D was associated with 4% higher odds (95% CI 1.008–1.076, P = .01) of CVD events; however, when
MedDietScore was entered in the model, CES-D lost its signiﬁcance (P = .20). Conclusion. Short-term depressive symptoms are
related to a worsen 30-day prognosis of ACS patients; however, this relationship was mediated by Mediterranean diet adherence.
1.Introduction
Depression has been recognized as an independent predictor
forthedevelopmentofcoronaryheartdisease(CHD)among
healthy and, especially, elderly individuals. Rugulies [1], in a
recent meta-analysis, reported that depression increases the
risk of myocardial infarction (MI) and coronary death, while
that risk is not limited to patients with clinical depression.
Similarly, in patients recovering from an acute coronary
syndrome (ACS), even the presence of mildly elevated
depressive symptoms is associated with a worse prognosis
[2]. Additionally, a linear association seems to exist between
the occurrence of depressive symptomatology at the time
of an MI and the risk of subsequent cardiac morbidity and
mortality [3, 4].
During the past 30 years, several observational studies
and clinical trials have provided scientiﬁc evidence that the
Mediterranean diet is associated with decreased all-cause
mortality and improvements in cardiovascular risk factors
levels [5, 6]. From the late 1960s, Keys and his colleagues
from the Seven Countries study underlined the eﬀect of
the dietary habits observed in Mediterranean populations
on cardiovascular disease risk [7]. De Lorgeril et al., from
the Lyon Heart Study, that was a randomized secondary
prevention clinical trial of CHD patients, revealed the
protective eﬀect of this traditional dietary pattern on cardiac2 Cardiology Research and Practice
complications of the patients within the ﬁrst 27 months of
followup after an acute coronary event [8]. A more recent
studyinACSpatientsillustratedthatgreateradherencetothe
Mediterranean diet seems to preserve left ventricular systolic
function and is associated with better long-term prognosis of
[9].
Although it is generally accepted that depression is
independently associated with a worse cardiac prognosis,
controversy persists whether this association is a reﬂection
of cardiac disease severity, as some studies have reported
signiﬁcant univariate associations, but have failed to ﬁnd
a signiﬁcant relationship after adjustment for markers of
cardiac disease severity [10, 11]. Furthermore, other pro-
tective lifestyle factors may play a mediator role in the
eﬀect of depressive symptomatology on clinical outcome.
Among those lifestyle factors, healthy dietary habits due to
their anti-inﬂammatory and antioxidative properties have
revealed cardioprotective eﬀect [8, 9]. Finally, it is well
known that the elderly represent the fastest growing segment
of the population. In addition, although it is widely adopted
that the risk for CVD is an exponential function of age,
because of various functional changes observed, the rate of
these changes varies greatly among elderly individuals. The
relationship between depression and cardiovascular health
may also be attributed to lifelong behavioral and lifestyle.
The purpose of this work was to evaluate the role of
short-term depressive symptoms in relation to dietary habits
on the short-term (i.e., 30-day) clinical outcome of elderly
patients who survived ACS.
2. Methods
2.1. Study’s Sample. From May 2006 to March 2009, 1000
of the 1257 consecutive patients who were hospitalised in
our Institution for an ACS (ﬁrst or recurrent) were enrolled
in the study (participation rate 80%); nonparticipants were
patients who denied to provide the requested information
or died during the ﬁrst 48 hours of hospitalization. For the
present analysis, 277 elderly (i.e., >65 years) patients (75
± 6 years, 70% males, 70% had a diagnosis of myocardial
infarction) that gave the requested information regarding
psychological evaluation were studied.
2.2. Bioethics. The study was approved by the Medical
Research Ethics Committee of our Institution and was
carried out in accordance with the Declaration of Helsinki
(1989) of the World Medical Association. All patients were
informed about the aims and procedures of the Study and
gave their consent to participate.
2.3. Diagnosis of ACS. At entry, a 12-lead electrocardiogram
was performed and clinical symptoms were evaluated in
all patients by a cardiologist. Moreover, blood tests were
performed to detect evidence of myocardial cell death
(i.e., Troponin I and the MB fraction of total creatinine
phosphokinase (CPK)). As mentioned above, the study’s
sample included only cases with diagnoses of ACS (i.e.,
acute myocardial infarction (MI) or unstable angina (UA)).
Acute MI was deﬁned according to the latest guidelines
[12] based on ECG ﬁndings and the aforementioned blood
tests. Additionally, unstable angina was deﬁned by the
occurrence of one or more angina episodes, at rest, within
the preceding 48-hours, corresponding to class III of the
Braunwald classiﬁcation [13].
2.4. Clinical and Biochemical Measurements. A detailed
medical history was recorded, including (i) previous hospi-
talization for CVD (coronary heart disease or stroke), (ii)
history and management of hypertension (deﬁned as systolic
or/and diastolic blood pressure >140/90mmHg or use
of antihypertensive medication), (iii) hypercholesterolemia
(deﬁnedasfastingserumtotalcholesterol>200mg/dLoruse
of lipid lowering agents), and (iv) diabetes mellitus (deﬁned
as fasting glucose >125mg/dL or use of special treatment),as
well as patients’ medical family history of CVD. Furthermore
the clinical course of all patients during hospitalization
was recorded, including coronary angiography results and
number of coronary vessels involved, thrombolysis, type of
revascularization (primary angioplasty, coronary artery by-
bass grafting), and time delay from the onset of symptoms to
the arrival at the hospital.
In addition to the clinical information, white blood
cell counts, uric acid, and brain natriuretic peptide (BNP)
were measured at the time of hospital admission. BNP
was determined by an enzyme-linked immunosorbent assay
(Biomedica, Vienna, Austria), with inter- and intra-assay
coeﬃcients of variation being <5% and with normal range
of 0–100pg/mL. Total cholesterol, high-density lipopro-
tein cholesterol, blood glucose, and triglycerides were
also measured in all participants at the time of hospital
admission using colorimetric enzymic method in a Tech-
nicon automatic analyzer RA-1000 (Dade-Behring Mar-
burg GmbH, Marburg, Germany). Low-density lipoprotein
cholesterol was calculated using the Friedewald formula:
total cholesterol—HDL cholesterol—1/5X (triglycerides).
An internal quality control was in place for assessing the
validity of cholesterol and triglycerides methods. The intra-
and interassay coeﬃcients of variation of cholesterol and
triglycerides levels did not exceed 4%. Renal function was
evaluated using the baseline creatinine clearance rate (CrCl)
that was calculated using the Cockcroft-Gault formula: CrCl
= [[(140 − age) × weight]/(72 × serum creatinine)] for
men, while for women, the result of the above equation
was multiplied by 0.85. A Roche/Hitachi Modular analyzer
was used (Roche Diagnostics, Manheim, Germany) for
all biochemical measurements. The biochemical evaluation
was carried out in the same laboratory that followed the
criteria of the World Health Organization Lipid Reference
Laboratories. Samples were immediately processed for the
determination of all biochemical parameters.
2.5. Demographic, Anthropometric, and Lifestyle Characteris-
tics. Sociodemographic characteristics included age and sex.
Height and weight were measured to the nearest 0.5cm and
100g, respectively. Body mass index (BMI) was calculated
as weight (in kilograms) divided by height (in meters)
squared. Obesity was deﬁned as BMI greater than or equal to
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during the past year, a modiﬁed version of a self-reported
questionnaire provided by the American College of Sports
Medicine was used [14]. Based on this questionnaire, the
frequency (times per week), duration (in minutes per time)
andintensityofsportsoroccupation-relatedphysicalactivity
were evaluated. Patients who did not report any physical
activities were deﬁned as sedentary. Current smokers were
deﬁned as those who smoked at least one cigarette per day or
have stopped cigarette smoking during the past 12 months.
Former smokers were deﬁned as those who had stopped
smoking more than one year previously. The rest of the
patients were deﬁned as never smokers or rare smokers.
2.6. Dietary Assessment and Evaluation of Adherence to the
Mediterranean Diet. The dietary evaluation took place after
the third day of hospitalization. Usual dietary intake over the
year preceding hospitalization was assessed in all patients by
a validated, semiquantitative food frequency questionnaire
[15]. The questionnaire included 75 items (i.e., foods and
beverages commonly consumed in Greece, as well as dietary
habits). Portion sizes were included in the food frequency
questionnaire to assist patients to report accurate informa-
tionandtoquantifydietaryhabits.Alcoholconsumptionwas
measured in wineglasses (100mL) and quantiﬁed by ethanol
intake (grams per drink). One wineglass was equal to 12g
ethanol concentration. The MedDietScore was calculated for
each participant in order to evaluate the level of adherence
to the Mediterranean diet. In particular, intake of 10 food
groups was evaluated (i.e., nonreﬁned cereals and products,
fruits and nuts, vegetables, olive oil, dairy, ﬁsh, poultry,
potatoes, pulses, red meat or meat products, and eggs),
as well as alcohol drinking. The diet score was calculated
as follows: for the consumption of items presumed to be
close to the Mediterranean pattern (i.e., nonreﬁned cereals
and products, fruits and nuts, vegetables, olive oil, non-
fat or low fat dairy, ﬁsh, potatoes and pulses), score 0
was assigned when a patient reported no consumption, 1
when reported consumption of 1 to 4 times/month, 2 for
5t o8t i m e s / m o n t h ,3f o r9t o1 2t i m e s / m o n t h ,4f o r
13 to 18 times/month, and 5 for more than 18 times per
month. For the consumption of foods presumed to be away
from this diet (like meat or meat products, eggs, poultry,
and dairy), reverse scores were assigned (i.e., 0 when a
patient reported almost daily consumption to 5 for rare
or no consumption). Regarding alcohol intake, score 5 was
assigned for consumption of less than 3 wineglasses per day,
0 for none or consumption of more than 7 wineglasses per
day, and scores of 4, 3, 2, and 1 for the consumption of 3,
4-5, 6, and 7 wineglasses, respectively. This nonmonotonic
scoring follows the rationale of the Mediterranean dietary
pattern that suggests an intake of 15–30g of ethanol per day.
Higher values of this diet score indicate greater adherence
to the Mediterranean diet (theoretical range 0–55), and have
already been associated with CVD risk and markers [16].
2.7. Assessment of Depressive Symptoms. Clinical symptoma-
tology of depression during the past month was determined
by a specialised, conﬁdential and weighted questionnaire,
whichwasbasedonaself-reporteddepressionscale(range0–
60) developed by Radloﬀ, known as the Center of Epidemi-
ological Studies-Depression scale (CES-D) and validated
for the Greek population, by Fountoulakis et al. [17].
The aforementioned scale has been found a reliable and
valid measure of depressive symptomatology [18]. Since
no accurate cut-oﬀs have been proposed for the Greek
population the tertiles of the CES-D score were used to
classify the patients. Thus, the participants were divided in
three equal size categories (tertiles): (a) 1st tertile (CES-D <
6), that represents rare symptoms, (b) 2nd tertile (18 < CES-
D < 26), that represents moderate symptoms, and (c) 3rd
tertile (CES-D > 26), that represents more severe symptoms.
The questions used for the evaluation of the investigated
emotionsarelistedbelow:“Howoftenduringthepastmonth
you...” were bothering by things that usually do not bother
you; had poor appetite; feeling that you could not shake oﬀ
the blues even with help from your family; feeling of being
just as good as other people; trouble keeping your mind on
what you were doing; feeling that everything you did was
an eﬀort; feeling hopeful about your future; thought that
your life had been a failure; feeling fearful; having restless
sleep; being happy; talking less than usual; feeling lonely;
considering people being unfriendly to you; enjoying your
life; having crying spells; feeling sad; feeling that people
disliked you; could not get “going”.
2.8. Follow-Up of the Patients. The lost to follow up rate was
10% for the 30-days, re-evaluations. Patients lost to follow-
up were considered as missing cases. The follow up of the
patientsincludedevaluationforvitalstatus(deathfromCVD
or other cause) and rehospitalization due to acute coronary
syndrome(i.e.,acuteMIorunstableanginaasdeﬁnedabove)
or other cardiac symptoms (i.e., arrhythmias, stable angina).
2.9. Statistical Analysis. Power analysis (GPower 3.1.1, Ger-
many) showed that the number of enrolled participants
(n = 277) is adequate to evaluate a 0.05 change in the
odds ratio of developing a 30-day adverse CVD event per
1-unit change in the CES-D score used, achieving statistical
power equal to 98% at 5% signiﬁcance level. Normally
distributed continuous variables are presented as mean
values ± standard deviation, skewed variables are presented
as median and quartiles, while categorical variables are
presented as relative (%) frequencies. Associations between
normally distributed continuous variables and group of
patients were evaluated through the Student’s t-test, after
controlling for equality of variances (homoscedacity) using
the Levene test. The associations between skewed variables
(i.e., Troponin I, BNP, glucose, triglycerides) and group of
patients were evaluated through the Mann-Whitney test.
Associations between categorical variables were evaluated
by the use of the chi-squared test, without the correction
of continuity. Correlations between continuous variables
were evaluated by the use of Pearson’s correlation coef-
ﬁcient for the normally distributed and by the Spear-
man’s rho coeﬃcient for the ordinal or skewed variables.
Normality was evaluated through the Shapiro-Wilktest.4 Cardiology Research and Practice
The association between the MedDietScore and CES-D score
with the occurrence of a CVD event was evaluated using
multiple logistic regression analyses, after controlling for
socio-demographic, clinical, and biochemical characteristics
of the patients. Appropriate tests for goodness-of-ﬁt (i.e.,
Hosmer-Lemeshow and deviance residuals) were applied
in all models. Results are presented as odds ratios and
their corresponding 95% conﬁdence intervals. All statistical
calculations will be performed on the SPSS version 18
software (SPSS Inc, Chicago, Il, USA).
3. Results
The follow-up evaluation of the patients showed that
22% had a CVD event during the ﬁrst 30-days following
hospitalization (14.8% were re-hospitalised and 9.4% died).
Regarding in-hospital mortality, 6% of the ACS patients died
whilehospitalized.Therewerenogenderdiﬀerencesbetween
those who developed an adverse cardiac event compared
to the rest. In Table 1 clinical, biochemical and lifestyle
characteristics of the patients who developed or not an
adverse CVD during the 30-day followup are presented.
Moreover, patients in the upper tertile of the CES-D scale
(i.e., >18) had higher incidence of 30-day CVD events as
compared with those in the lowest tertile (21% versus 8%,
P = .01); in addition they were more likely to be females
(48% versus 10%, P = .001), they had higher prevalence
of hypertension (88% versus 63%, P = .05) and lower
current smoking habits (27% versus 20%, P = .05), while
no diﬀerence was observed according to diabetes mellitus
history, physical activity status, dietary habits, BMI, left
ventricular ejection fraction, and previous history of CVD.
In Table 2, clinical, biochemical, and lifestyle charac-
teristics of the patients who developed or not an adverse
CVD during the 30-day followup by the tertile of the
MedDietScore (<16, 16–19, >19) are presented. Among
all tertiles of MedDietScore, those patients who presented
an adverse cardiac event had lower prevalence of smoking
habits, higher plasma BNP levels, higher prevalence of
myocardial infarction than unstable angina, lower creatinine
clearance levels, more advance age, higher CES-D score,
higher diabetes mellitus prevalence, and lower left ventric-
ular ejection fraction.
From the abovementioned results, it seems that a posi-
tive relationship between depression status and short-term
prognosis of ACS patients exists. However, residual con-
founding may be present, since several clinical, lifestyle, and
behavioural characteristics were associated with adherence
to the depression status, as well as the prognosis of the
patients. In addition, a signiﬁcant interaction was observed
between CES-D score and MedDietScore (P = .03); thus,
the following analysis was stratiﬁed by dietary habits class
(i.e., away, close, and very close to the Mediterranean diet).
Multiadjustedanalysesrevealedthatone-unit increase(1/60)
in the Depression scale was associated with 4% higher odds
of developing 30-day adverse cardiac event after discharge,
controlling physical activity status, age, gender, BMI, smok-
ing habits, history of hypertension, hypercholesterolemia,
diabetes, ﬁrst event of CVD, and left ventricular ejection
fraction. When in the model the MedDietScore was entered,
CES-D variable lost its signiﬁcance, suggesting a strong
mediating eﬀect (Table 3).
4. Discussion
This study demonstrated that the relationship between
depression and CVD development following an ACS in
elderly patients is mediated by dietary habits. In particular,
previous depression status was initially associated with the
development of CVD events; however, when dietary habits
were taken into account this relationship was lost. The
ﬁndings were independent of several potential cofounders
such as sex, age, ejection fraction of the left ventricle,
body mass index, smoking habits, history of CVD, diabetes
mellitus, hypercholesterolemia, hypertension, number of
vessel disease, revascularization, and physical activity status.
Previous studies have shown that even minor elevations
in depressive symptoms (subthreshold depression, deﬁned
to include mood, somatic, and interpersonal symptoms of
depression, but not necessarily a diagnosable depressive
disorder) signiﬁcantly increase the risk of incidence of CHD
among previously healthy participants or worsen the cardiac
prognosis in patients with established CHD [19–21]. The
scientiﬁc evidence is strongest for patients who have been
hospitalized for an ACS, that is, MI or unstable angina [22].
Similarly, according to the GREECS study, which included
2172patientswithACS,theshort-termdepressivesymptoms
are related to more severe disease and a worsen 30-day
prognosis of patients hospitalized for ACS [23].
Despite the consistency of the ﬁndings in these reviews,
it remains unclear why a number of individual studies with
robust methodologies have failed to show an adverse eﬀect
of depression on mortality especially among the elderly [24,
25]. Furthermore, psychological interventions have failed to
show a reduction in mortality, which would be expected
if depression caused an increase in mortality [26]. The
conﬂicting results of previous studies may be attributable to
the way depression is measured, because diﬀerent measures
may be sensitive to diﬀerent dimensions of depression, or
duration of followup [19]. Furthermore, variation in timing
of the assessments and variable attempts to control for
the confounding eﬀect of severity of heart disease may
be also responsible for the heterogeneity [27]. However,
what are less established are the mechanisms responsible
for the eﬀect of depression on cardiovascular risk [28].
It has been reported that depression might increase CHD
incidenceandmortalitybypromotingfactorsassociatedwith
coronary atherosclerosis. The eﬀect of depressive symptoms
may be direct, inducing cardiac ischemia, increasing the risk
for cardiac arrhythmias and sudden death, increasing the
levels of blood lipids, platelets, and inﬂammatory factors,
as well as indirect by promoting unhealthy behaviours,
like cigarette smoking, decreased adherence to medications,
physical inactivity, poor, unhealthy diet, and other lifestyle
characteristics [29]. Especially for the prognosis of CHD
patients, van Melle et al. [30] reported that among myocar-
dial infarction survivors, the rate of depression and the
severity of depressive symptoms were signiﬁcantly relatedCardiology Research and Practice 5
Table 1: Clinical, biochemical, and lifestyle characteristics of ACS elderly patients (n = 277), according to the development of 30-day CVD
events.
30-day CVD event Free of 30-day CVD event P-value
N, (%) 61 (22) 216 (78)
Age (yrs) 76 ± 67 4 ± 6 .036
Gender (%male) 69 70 .82
Body mass index (kg/m2) 26.7 ± 5.2 28 ± 5 .197
Hospital admission variables
MI (%) 85 67 .001
First CVD event (%) 52% 56% .672
Ejection Fraction (%) 33 44 .001
Revascularization (%) 33% 27% .347
Creatinine Clearance (mL) 49.22 ± 23 60.2 ± 22 .003
Troponin I (ng·mL) 10.22 ± 22 8.3 ± 2.1 .56
Glucose levels (mg/dL) 189.5 ± 118.7 161 ± 79.4 .034
BNP (pg/mL) 943 ± 148 475 ± 66 .005
Medical history variables
CES- scale (0–60) 34.20 ± 18.44 22.68 ± 12.5 .007
Physical active (%) 51% 59% .376
Smoking current (%) 31% 30% .865
Hypercholesterolaemia (%) 71% 53% .013
Hypertension (%) 71% 72% .901
Diabetes mellitus (%) 45% 41% .551
MedDietScore 17.5 ± 4 18.1 ± 4. 0 5
Systolic blood pressure 125 ± 29 134 ± 24 .064
Table 2: Clinical, biochemical, and lifestyle characteristics of ACS elderly patients (n = 277), according to the development of 30-day CVD
events and their dietary habits.
MedDietScore (0–55)
Lowest tertile (<16) Middle tertile (16–19) Upper tertile (>19)
30-day CVD event 30-day CVD event 30 day event
Yes No P Yes No P Yes No P
N, % 31 78 8 75 22 63
Age (yrs) 77 ±67 6 ±6 .731 76 ±67 5 ±6 .707 75 ±67 5 ±5 .767
Gender (%male) 57 59 .918 35 38.5 .632 34.5 46 .003
Hospital admission variables
MI (%) 95 74 .001 50 61 .745 60 74 .458
First CVD event (%) 43 50 .664 50 39 .745 40 56 .425
Ejection Fraction (%) 34.5 35 .822 57.53.6 56.6 ±23 .859 65 ±25 63 ±19 .817
Revascularization (%) 42 23 .229 25 18 .807 50 52 .925
Creatinine Clearance (mL) 41.37 ±24.94 58.36 ±24.74 .044 50 76 .444 80 81 .924
Troponin I (ng·mL) 6.71 ±9.77 10.57 ±21.6 .415 9.5 ±13 6.67 ±17 .751 12.4 ±27 9.9 ±28 .819
BNP (pg/mL) 1089 ±1043 642 ±714 .241 1460 ±1045 629 ±870 .453 744 ±440 375 ±490 .09
Medical history variables
CES- scale (0–60) 21 ±24 19 ±9 .947 34 ±19 25 ±15 .924 41 ±20 31 ±13 .467
BMI (kg/m2)2 5 .4 ±3.22 7 .5 ±3.7 .057 33 ±7.52 6 .9 ±4 .295 27 ±42 8 .5 ±9 .487
Physical active (%) 36 47 .482 67 61 .875 70 70 .984
Smoking current (%) 14 32 .164 67 33 .424 30 30 .984
Hypercholesterolaemia (%) 57 53 .808 67 55 .755 80 65 .384
Hypertension (%) 64 62 .238 100 69 .001 70 70 .984
Diabetes mellitus (%) 43 53 .541 67 48 .645 60 33 .1766 Cardiology Research and Practice
Table 3: Results from additive logistic regression models that evaluated the association of CES-D score on the likelihood of developing
30-day CVD events among n = 277 elderly ACS survivors.
OR (95% CI) OR (95% CI) OR (95% CI)
CES-D (per 1/60 units) 1.011 (0.98–1.046) 1.042 (1.008–1.076) 1.025 (0.987–1.065)
First coronary event (Y/N) 0.909 (0.43–1.889) 0.505 (0.210–1.217) 0.63 (0.234–1.693)
Age (per 1 year) 1.015 (0.985–1.045) 1.018 (0.946–1.096) 0.987 (0.908–1.072)
Male versus female gender 1.118 (0.495–2.524) 0.568 (0.224–1.438) 0.731 (0.258–2.067)
Revascularization (Y/N) — 2.453 (0.97–6.305) 2.477 (0.866–7.086)
Physical activity (Y/N) — 1.138 (0.476–2.723) 0.868 (0.325–2.318)
Current smoking habits (Y/N) — 0.668 (0.23–1.941) 0.688 (0.215–2.202)
Body Mass Index (per 1kg/m2) — 0.946 (0.853–1.048) 0.961 (0.866–1.067)
Hypercholesterolemia (Y/N) — 1.869 (0.762–4.586) 1.246 (0.46–3.37)
Hypertension (Y/N) — 0.983 (0.378–2.551) 0.876 (0.294–2.604)
Diabetes mellitus (Y/N) — 1.009 (0.432–2.354) 1.139 (0.428–3.033)
Ejection fraction (per 1%) — 0.935 (0.897–0.975) 0.951 (0.903–1.001)
MedDietScore (per 1/55 units) — — 0.989 (0.866–1.130)
to the severity of left ventricular dysfunction, giving a
potential pathophysiological mechanism for the prognosis
of patients with depressive symptoms. Moreover, Carney et
al. [31] suggested that the dys-regulation of the autonomic
nervous system may partially mediate the increased risk for
mortality in depressed myocardial infarction patients with
frequent ventricular contractions. Furthermore, depression
isassociatedwithpoorsecondarypreventionamongpatients
who have had an acute ischemic event. In the large Heart
and Soul study [32] of patients with depression and CHD,
an association between depressive symptoms and adverse
cardiovascular events was largely explained by behavioral
factors, especially physical inactivity. It is also illustrated in
otherstudiesthatunhealthybehaviorsaccompanydepressive
symptomatology and can mainly explain the occurrence of
adverse cardiovascular events [33].
In the present work, when MedDietScore, that evaluates
the level of adherence to a healthy dietary pattern, was
included in the analysis, the depression variable lost its
signiﬁcant for the occurrence of adverse cardiac events
during the short-term followup. Additionally, the 30-day
outcomewasinverselyrelatedtoMedDietScore.Thepossible
cardioprotective eﬀects of Mediterranean diet became widely
known for the ﬁrst time in the 1970s from the Seven
Countries Study [7]. Since then, there are numerous indi-
cations that adoption of a Mediterranean diet is associated
with decreased all-cause mortality and improvements in
cardiovascular risk factors levels [34, 35] due to the diet’s
antithrombotic, anti-inﬂammatory, and antioxidant eﬀects
[36, 37]. Among those studies, the HALE project revealed
the protective eﬀect of Mediterranean type of diet on
cardiovascular and total mortality in elderly individuals
[38]. It is known that inﬂammation and oxidative stress
accompany the clinical presentation and course of an ACS,
aﬀecting infarct size. Infarct size determines postinfarction
survival and prognosis, as it is the most important factor of
ventricular remodelling process and left ventricular systolic
function. Olive oil, which is the main source of fat in the
Mediterranean type of diet, is rich in oleuropein, which
has been shown to reduce the infarct size, in experimental
models [39, 40], and also to protect reperfused myocardium
from oxidative damage “in vivo,” resulting in more preserved
left ventricular systolic function [41]. In a recent study [9],
it was revealed that ACS patients that had closer adherence
to the Mediterranean diet preserved left ventricular systolic
function, while they showed less in-hospital deaths and
cardiovascular events during the two-years of followup.
These ﬁndings were unaltered after controlling for several
patient characteristics, like lifestyle behaviours, medical
history as well as biological factors at hospital admission.
Those cardioprotective mechanisms of Mediterranean diet
might modify beneﬁcially the adverse eﬀects of depression
symptomatology on cardiovascular system.
5. Limitations
The present work has several strengths mentioned above,
but also some limitations. For example, only survivors of
ACS were studied. Thus, there is no information from
patients who died during the ﬁrst two days of hospitalization
(approximately 2% of the total hospitalizations). For the
dietary evaluation, a holistic dietary approach using food
patterns (i.e., Mediterranean diet) and not single food
approach was used. The rationale of this approach was that
overall diet assessment represents a broader picture of food
and nutrient consumption of real life. Furthermore, dietary
patterns capture the extremes of dietary habits, preempts
nutritional confounding, possible eﬀect modiﬁcation among
nutritional variables through the same procedure, and they
do not tend to be biased.
6. Conclusion
This study highlights the eﬀectiveness of adhering to the
Mediterranean diet on cardiac events following ACS, espe-
cially for elderly individuals with depression. Regardless ofCardiology Research and Practice 7
any drug treatment prescribed, clinicians should routinely
advise patients with acute coronary syndromes to increase
theirfrequencyofconsumptionofMediterraneanfoods,asit
seems that this type of diet can attenuate the adverse eﬀects
of depression on cardiovascular health. Further studies are
needed to investigate the most eﬀective way to treat patients
suﬀering from depressive symptoms and convince them to
follow more healthy dietary patterns and a healthy lifestyle in
general.
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